Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy
Clinical trial NCT04542993 · TERMINATED
Trial details
- NCT number
- NCT04542993
- Sponsor
- Swedish Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-08
- Primary completion
- 2021-02-05
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.